| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.006 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.006 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.007 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.09 | 0.008 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.009 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |